Advanced search
Publication Cover
Nanomedicine Volume 9, 2014 - Issue 7
Submit an article Journal homepage
151
Views
0
CrossRef citations to date
0
Altmetric
Preliminary Communication

Biphasic Magnetic Nanoparticles–Nanovesicle Hybrids for Chemotherapy and Self-Controlled Hyperthermia

Manashjit Gogoi1 Wadhwani Research Centre in Biosciences & Bioengineering, Department of Biosciences & Bioengineering, Indian Institute of Technology, Bombay, Mumbai400076, IndiaView further author information
,
Haladhar D Sarma2 Radiation Biology & Health Sciences Division, Bhabha Atomic Research Centre, Mumbai400085, IndiaView further author information
,
Dhirendra Bahadur3 Department of Metallurgical Engineering & Materials Science, Indian Institute of Technology, Bombay, Mumbai400076, IndiaView further author information
&
Rinti Banerjee1 Wadhwani Research Centre in Biosciences & Bioengineering, Department of Biosciences & Bioengineering, Indian Institute of Technology, Bombay, Mumbai400076, IndiaCorrespondence[email protected]
View further author information
Pages 955-970 | Received 15 May 2012, Published online: 30 Jun 2014

References

  • Jordan A , ScholzR, Maier-HauffKet al. Presentation of a new magnetic field therapy system for the treatment of human solid tumors with magnetic fluid hyperthermia. J. Magn. Magn. Mater. 225 (1–2), 118–126 (2001).
  • Schneiderman MH , HoferKG, SchneidermanGS. Targets for radiation-induced cell death: when DNA damage doesn‘t kill. Radiat. Res.155(4), 529–535 (2001).
  • Gogoi M , JaiswalMK, BanerjeeR, BahadurD. Magnetic nanovesicles and hydrogels towards cancer therapy. In: Magnetic Nanoparticles from Fabrication to Clinical Applications. Thanh NTK (Ed.). CRC Press, London, UK, 479–498 (2011).
  • Kizaka-Kondoh S , InoueM, HaradaH, HiraokaM. Tumor hypoxia: a target for selective cancer therapy. Cancer. Sci.94(12), 1021–1028 (2003).
  • Jain RK . Normalization of tumor vasculature: an emerging concept in antiangiogenic therapy. Science307, 58–62 (2005).
  • Bouzin C , FeronO. Targeting tumor stroma and exploiting mature tumor vasculature to improve anti-cancer drug delivery. Drug Resist. Updat.10(3), 109–120 (2007).
  • Streffer C . Molecular and cellular mechanisms of hyperthermia. In: Thermoradiotherapy and Thermochemotherapy. Seegenschimicdt MH, Fessenden P, Vernon CC (Eds). Springer Verlag, Berlin, Germany, 47–74 (1995).
  • Hildebrandt B , WustP, AhlersOet al. The cellular and molecular basis of hyperthermia. Crit. Rev. Oncol. Hematol. 43(1), 33–56 (2002).
  • Kong G , DewhirstMW. Hyperthermia and nanovesicles. Int. J. Hyperthermia15(5), 345–370 (1999).
  • Kong G , BraunRD, DewhirstMW. Characterization of the effect of hyperthermia on nanoparticle extravasation from tumor vasculature. Cancer Res.61, 3027–3032 (2001).
  • Yanase M , ShinkaiM, HondaH, WakabayashiT, YoshidaJ, KobayashiT. Intracellular hyperthermia for cancer using magnetite cationic nanovesicles: an in vivo study. Jpn J. Cancer Res.89, 463–469 (1998).
  • Ito A , TanakaK, HondaH, AbeS, YamaguchiH, KobayashiT. Complete regression of mouse mammary carcinoma with a size greater than 15 mm by frequent repeated hyperthermia using magnetite nanoparticles. J. Biosci. Bioeng.96(4), 364–369 (2003).
  • Pradhan P , GiriJ, RiekenFet al. Targeted temperature sensitive magnetic nanovesicles for thermo-chemotherapy. J. Control. Release 142(1), 108–121 (2010).
  • Dilnawaz F , SinghA, MohantyC, SahooSK. Dual drug loaded superparamagnetic iron oxide nanoparticles for targeted cancer therapy. Biomaterials31(13), 3694–3706 (2010).
  • Kulshrestha P , GogoiM, BahadurD, BanerjeeR. In vitro application of paclitaxel loaded magnetonanovesicles for combined chemotherapy and hyperthermia. Colloid. Surf. B Biointerfaces96, 1–7 (2012).
  • Zhang J , MisraRDK. Magnetic drug-targeting carrier encapsulated with thermosensitive smart polymer: core-shell nanoparticle carrier and drug release response. Acta Biomater.3, 838–850 (2007).
  • Shido Y , NishidaY, SuzukiY, KobayashiT, IshiguroN. Targeted hyperthermia using magnetite cationic nanovesicles and an alternating magnetic field in a mouse osteosarcoma model. J. Bone Joint Surg. Br.92(4), 580–585 (2010).
  • Vasseur S , DuguetE, PortierJet al. Lanthanum manganese perovskite nanoparticles as possible in vivo mediators for magnetic hyperthermia. J. Magn. Magn. Mater. 302(2), 315–320 (2006).
  • Liangruksa M , GangulyR, PuriIK. Parametric investigation of heating due to magnetic fluid hyperthermia in a tumor with blood perfusion. J. Magn. Magn. Mater.323(6), 708–716 (2011).
  • Kuznetsov AA , LeontievVG, BrukvinVAet al. Local radiofrequency-induced hyperthermia using CuNi nanoparticles with therapeutically suitable Curie temperature. J. Magn. Magn. Mater. 311(1), 197–203 (2007).
  • Pollert E , KnízekK, MaryskoM, KasparP, VasseurS, DuguetE. New Tc-tuned magnetic nanoparticles for self-controlled hyperthermia. J. Magn. Magn. Mater.316(2), 122–125 (2007).
  • Shlyakhtin OA , LeontievVG, OhY, KuznetsovAA. New manganite-based mediators for self-controlled magnetic heating. Smart Mater. Struct.16(5), N35–N39 (2007).
  • Prasad N , RathinasamyK, PandaD, BahadurD. Tc-tuned biocompatible suspension of La0.73Sr0.27MnO3 for magnetic hyperthermia. J. Biomed. Mater. Res. B Appl. Biomater.85, 409–416 (2008).
  • Rowinsky EK , DonehowerRC. Paclitaxel (Taxol). N. Engl. J. Med.332, 1004–1014 (1995).
  • McMullen TPW , McElhaneyRN. Differential scanning calorimetric studies of the interaction of cholesterol with distearoyl and dielaidoyl molecular species of phosphatidylcholine, phosphatidylethanolamine, and phosphatidylserine. Biochemistry36, 4979–4986 (1997)
  • Prasad NK , HardelL, DuguetE, BahadurD. Magnetic hyperthermia with biphasic gel of La1-xSrxMnO3 and maghemite. J. Magn. Magn. Mater.321, 1490–1492 (2009).
  • Shiigi SM , SlomichM. Heterologous antisera to mouse brain. In: Selected Methods in Cellular Immunology. Mishell BB, Shiigi MS (Eds). WH Freeman Co., CA, USA, 247–257 (1980).
  • Cullity BD , GrahamCD. Introduction to Magnetic Materials (2nd Edition). John Wiley & Sons Inc., NJ, USA (2008).
  • Vichai V , KirtikaraK. Sulforhodamine B colorimetric assay for cytotoxicity screening. Nat. Protoc.1, 1112–1126 (2006).
  • Anand P , HuilgolN, BanerjeeR. Effect of fluidizing agents on paclitaxel penetration in cervical cancerous monolayer membranes. J. Membr. Biol.219, 83–91 (2007).
  • Zhang Y , TangL, SunLet al. A novel paclitaxel-loaded poly(epsilon-caprolactone)/Poloxamer 188 blend nanoparticle overcoming multidrug resistance for cancer treatment. Acta Biomater. 6, 2045–2052 (2009).
  • Jin C , BaiL, WuH, TianF, GuoG. Radiosensitization of paclitaxel, etanidazole and paclitaxel+etanidazole nanoparticles on hypoxic human tumor cells in vitro. Biomaterials28, 3724–3730 (2007).
  • Semple SC , ChonnA, CullisPR. Influence of cholesterol on the association of plasma proteins wit liposomes. Biochemistry35, 2521–2525 (1996).
  • Gabizon A , ChemlaM, TzemachD, HorowitzAT, GorenD. Nanovesicle longevity and stability in circulation: effects on the in vivo delivery to tumors and therapeutic efficacy of encapsulated anthracyclines. J. Drug Targeting3, 391–398 (1996).
  • Parr MJ , MasinD, CullisPR, BallyMB. Accumulation of liposomal lipid and encapsulated doxorubicin in murine Lewis lung carcinoma: the lack of beneficial effects by coating nanovesicles with poly(ethylene glycol). J. Pharmacol. Exp. Ther.280, 1319–1327 (1997).
  • Mayer LD , CullisPR, BallyMB. Designing therapeutically optimized liposomal anticancer delivery systems: lessons from conventional nanovesicles. In: Medical Applications of Nanovesicles. Lasic DD, Papahadjopoulos D (Eds). Elsevier, Amsterdam, The Netherlands, 231–257 (1998).
  • Hong RL , HuangCJ, TsengYLet al. Direct comparison of liposomal doxorubicin with or without polyethylene glycol coating in C-26 tumor-bearing mice is surface coating with polyethylene glycol beneficial? Clin. Cancer Res. 5, 3645–3652 (1999).
  • Kohler N , SunC, FichtenholtzA, GunnJ, FangC, ZhangM. Methotrexate-immobilized poly(ethylene glycol) magnetic nanoparticles for MR imaging and drug delivery. Small2, 785–792 (2006).
  • Chouly C , PouliquenD, LucetI, JeuneJJ, JalletP. Development of superparamagnetic nanoparticles for MRI: effect of particle size, charge and surface nature on biodistribution. J. Microencapsul.13, 245–255 (1996).
  • Arias JL , RuizMA, GallardoV, DelgadoAV. Tegafur loading and release properties of magnetite/poly(alkylcyanoacrylate) (core/shell) nanoparticles. J. Control. Release125, 50–58 (2008).
  • Kim SY , LeeYM. Taxol-loaded block copolymer nanospheres composed of methoxy poly(ethylene glycol) and poly(epsilon-caprolactone) as novel anticancer drug carriers. Biomaterials22, 1697–1704 (2001).
  • Chattopadhyay P , GuptaRB. Supercritical CO2 based production of magnetically responsive micro- and nanoparticles for drug targeting. Ind. Eng. Chem. Res.41, 6049–6058 (2002).
  • Zhu L , MaJ, JiaN, ZhaoY, ShenH. Chitosan-coated magnetic nanoparticles as carriers of 5-fluorouracil: preparation, characterization and cytotoxicity studies. Colloid. Surf. B Biointerface68, 1–6 (2009).
  • Luo S , ZhangE, SuY, ChengT, ShiC. A review of NIR dyes in cancer targeting and imaging. Biomaterials32, 7127–7138 (2011).
  • Links M , BrownR. Clinical relevance of the molecular mechanisms of resistance to anti-cancer drugs. Expert Rev. Mol. Med.1999, 1–21 (1999).
  • Krishna R , MayerL. Applications of nanovesicle technology to overcome multidrug resistance in solid tumors. In: Targeting of Drugs 6: Strategies for Stealth Therapeutic Systems (NATO ASI Series). Gregoriadis G, McCormack B (Eds). Plenum Press, NY, USA, 95–108 (1998).
  • Prasad NK , RathinasamyK, PandaD, BahadurD. Mechanism of cell death induced by magnetic hyperthermia with nanoparticles of γ-MnxFe2-xO3 synthesized by a single step process. J. Mater. Chem.17, 5042–5051 (2007).
  • Ito A , FujiokaM, YoshidaTet al. 4-S-cysteaminylphenol-loaded magnetite cationic nanovesicles for combination therapy of hyperthermia with chemotherapy against malignant melanoma. Cancer Sci. 98, 424–430 (2007).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.